Difference between revisions of "CT Coordinating Committee"
Jump to navigation
Jump to search
m |
|||
| (9 intermediate revisions by 2 users not shown) | |||
| Line 1: | Line 1: | ||
__NOTOC__ | __NOTOC__ | ||
| − | + | Co-Chairs: Andrew J. Buckler, MS; Rudresh Jarecha, MBBS, DNB, DMRE; James L. Mulshine, MD | |
| − | + | <br />RSNA Staff Support: Julie Lisiecki | |
| − | * [http://tinyurl.com/QIBA-CT-CC-Roster Roster] | + | * [http://tinyurl.com/QIBA-CT-CC-Roster '''Roster'''] |
| Line 16: | Line 16: | ||
==Meetings== | ==Meetings== | ||
| − | * | + | * WebEx calls are held Quarterly. Please contact RSNA Staff for details. |
| − | |||
Revision as of 23:33, 24 February 2021
Co-Chairs: Andrew J. Buckler, MS; Rudresh Jarecha, MBBS, DNB, DMRE; James L. Mulshine, MD
RSNA Staff Support: Julie Lisiecki
Scope
The CT Coordinating Committee coordinates Biomarker Committees based on CT.
- Considering and proposing new candidate Biomarker Committees to the Steering Committee
- Preparing/Reviewing and Prioritizing groundwork funding proposals for submission to the Steering Committee
- Approving for publication Biomarker Profiles developed by the CT Biomarker Committees
Meetings
- WebEx calls are held Quarterly. Please contact RSNA Staff for details.